Quote:The electoral college should be unfaithful
By Kathleen Parker Opinion writer
December 6
If you thought Donald Trump was the face of America’s anti-establishment movement, hold on to your chapeaus: A wild wind is rising.
Want to know what’s more anti-establishment than a president-elect who refuses to play by the rules? How about similarly spirited electors going AWOL and sending someone else to the Oval Office?
Could it happen? Might.
A movement headed by a mostly Democratic group calling itself Hamilton Electors is trying to persuade Republican electors to defect — not to cede the election to Hillary Clinton but to join with Democrats in selecting a compromise candidate, such as Mitt Romney or John Kasich. It wouldn’t be that hard to do.
Mathematically, only 37 of Trump’s 306 electors are needed to bring his number down to 269, one less than the 270 needed to secure the presidency.
On the Hamilton Electors’ Facebook page, elector Bret Chiafalo, a Democrat from Washington, explains the purpose of the electoral college. If you haven’t previously been a fan of the electoral system, you might become one.
Bottom line: The Founding Fathers didn’t fully trust democracy, fearing mob rule, and so created a republic. They correctly worried that a pure democracy could result in the election of a demagogue (ahem), or a charismatic autocrat (ahem), or someone under foreign influence (ditto), hence the rule that a president must have been born in the United States. We know how seriously Trump takes the latter.
Most important among the founders’ criteria for a president was that he (or now she) be qualified. Thus, the electoral college was created as a braking system that would, if necessary, save the country from an individual such as, frankly, Trump.
It is worth noting that 50 former Republican national security officials and foreign policy experts co-signed a letter saying that Trump would be a “dangerous president.” Do we simply ignore them?
At least one Republican elector, Christopher Suprun, has decided to pay heed. In an op-ed in Tuesday’s New York Times, Suprun, a paramedic in Texas, outlined all his reasons for not rubber-stamping Trump, saying he owes a debt not to his party but to his children. He urged others to join him.
This, apparently, they can do, though some states may impose penalties. Hamilton Electors are raising funds to pay any such costs that may accrue.
Paul Kane speaks to Libby Casey about President-elect Donald Trump's unfounded claim that millions of people voted illegally for Hillary Clinton. (The Washington Post)
Alexander Hamilton, suddenly a star on both Broadway and Main Street, wrote that the electoral college “affords a moral certainty that the office of President will never fall to the lot of any man who is not in an eminent degree endowed with the requisite qualifications.”
Electors would prevent the “tumult and disorder” that would result from the candidate’s exploiting “talents for low intrigue, and the little arts of popularity.” Speaking of Trump. How wise our founders were. And how unwise are we to pay so little attention to their far keener insights.
It is, perhaps, a sign of these upside-down times that Democrats, usually preferring the popular vote, are suddenly genuflecting to the electoral college and Republicans, who so often defer to the founders’ original intent, shift principle so swiftly, presumably in hopes of taking the ultimate escalator ride in the golden palace of King Trump. Tut-tut.
Meanwhile, those on both sides who remain opposed to Trump are dismissed as either sorry losers or as dining on crow and sour grapes. But the stakes are too high — and the evidence of Trump’s presidential aptitude deficit too severe — for such trivializing designations.
His demonstrated lack of judgment and impulse control should send shivers down the spines of all Americans in consideration of the nuclear arsenal he is poised to have at his fingertips.
The electoral college should be unfaithful By Kathleen
Top 10 Most Recent News Articles
Chemours Faces Class Action Over Fraud Allegations
Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...
Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety
Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...
Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?
A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...
Continue Reading
CapCut's AI Tools Reshape Video Content Creation
AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...
Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform
Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...
Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans
NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...
Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies
Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...
Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment
Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...
Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil
Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...
Continue Reading
What to Expect: Your First Therapy Session Insights
Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...
Continue ReadingTop 5 Most Recently Viewed Articles
Fresh Del Monte's Sustainability Report Shows Significant Progress
Fresh Del Monte's 2023 Sustainability Goals Fresh Del Monte Produce Inc. (NYSE: FDP), a prominent player in the global fruit and vegetable market, has released its sustainability report for the year, highlighting a remarkable journey toward environmental stewardship. This report showcases the substantial progress Fresh Del Monte has made in its sustainability initiatives,...
Continue Reading
MEXC Enhances User Security with New Compliance Measures
MEXC Enhances User Security with New Compliance Measures MEXC, a prominent cryptocurrency exchange renowned for its global reach, has taken significant steps to enhance risk control and compliance protocols aimed at safeguarding users and ensuring the market's integrity. The organization remains committed to eradicating fraudulent behaviors and enhancing compliance...
Continue Reading
Market Insights: Asian Shares and Economic Influences
Mixed Outcomes in Asian Markets Asian shares displayed a blend of positive and negative trends as markets reacted to the recent surge in U.S. stocks, which reached new peaks to end a successful trading week. U.S. futures reflected this mixed sentiment, while oil prices experienced an upward trend. Performance of Key Indices In Hong Kong, the Hang Seng index dropped 1.5%...
Continue Reading
Understanding Recent CPSC Recalls and Safety Measures
Understanding Recent CPSC Recalls and Safety Measures The Consumer Product Safety Commission (CPSC) plays a crucial role in safeguarding the public from hazards associated with consumer products. Recently, several recalls have been announced to protect consumers from potential risks. These recalls, conducted in cooperation with various firms, aim to address safety...
Continue Reading
Significant Advancements in Lymphedema Treatment Using Flexitouch® Plus
Groundbreaking Results from Flexitouch® Plus Study In an exciting development for medical technology, Tactile Systems Technology, Inc. (Nasdaq: TCMD) has presented remarkable findings from a recent late-breaking poster session at a prominent rehabilitation medicine conference. The data highlights the sustained clinical benefits of Flexitouch® Plus as a primary therapy...
Continue Reading